- Home
- IPDN vs APM Comparison
IPDN vs APM Comparison
Compare IPDN & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPDN | APM |
|---|---|---|
| Founded | 2003 | 2010 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 8.0M |
| IPO Year | 2012 | 2018 |
Fundamental Metrics
Financial Performance| Metric | IPDN | APM |
|---|---|---|
| Price | $1.66 | $0.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 204.5K | 40.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,054,219.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.22 | $0.65 |
| 52 Week High | $12.39 | $4.47 |
Technical Indicators
Market Signals| Indicator | IPDN | APM |
|---|---|---|
| Relative Strength Index (RSI) | 48.04 | 37.99 |
| Support Level | $1.47 | $0.76 |
| Resistance Level | $1.95 | $1.11 |
| Average True Range (ATR) | 0.22 | 0.06 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 31.91 | 52.20 |
Price Performance
Historical ComparisonAbout IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.